REVO Oncology Diagnostics Inc.

Healthtech Frisco, TX

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Healthtech
Headquarters
Frisco, TX
Street
2829 Spanish Moss Trail
Zip
75033

Offering

Total offering
$1.2M
Amount sold
$270k
First sale
Sep 17, 2025
Min investment
$0
Securities
Other
Federal exemption
Rule 506(b)
Investors so far
7

How this filing compares

Ranked #40 of 63 Healthtech filings in April 2026 by offering amount.

Median Healthtech filing in April 2026: $3.4M. This offering is 0.4× the median.

Other Texas filings this week: 1700 Northgate Partners LLC, 90Ten EDGE Central II Syndicate, LLC, Acacia Partners Investments IV - AI, LLC, Acacia Partners Investments IV - QP, LLC, Americana - LGP Series 2026, LP

Leadership

Estevan Kiernan — Executive Officer (also: Director)

Filing details

REVO Oncology Diagnostics Inc. filed a Form D with the SEC on April 13, 2026.

Other newest Healthtech companies

Other newest companies in Texas